Proof-of-concept for intervention to prevent post-operative ileus in patients undergoing ileostomy formation

Anya L Greenberg1, Yvonne M Kelly2, Ankit Sarin2

  • 1School of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Insights

A pilot intervention significantly reduced post-operative ileus (POI) in patients with ileostomies, lowering hospital stays and costs. Further research is needed to confirm these promising results for preventing POI.

Area of Science:

  • Colorectal Surgery
  • Surgical Outcomes
  • Enhanced Recovery After Surgery (ERAS) Protocols

Background:

  • Post-operative ileus (POI) increases patient morbidity and healthcare costs.
  • Prior research linked POI in ileostomy patients to a positive post-operative day 2 net fluid balance exceeding +800 mL.
  • An initial assessment of a pilot intervention's efficacy was conducted.

Purpose of the Study:

  • To assess the efficacy of a pilot intervention aimed at preventing post-operative ileus (POI) in patients with newly created ileostomies.
  • To evaluate the impact of the intervention on key outcomes including POI rates, length of stay, hospitalization costs, and readmissions.

Main Methods:

  • A single-institution, pre-post-intervention study involving 58 colorectal surgery procedures with ileostomy formation.
  • The intervention modified the Enhanced Recovery After Surgery (ERAS) protocol, incorporating diuresis, delayed solid food advancement, and earlier stoma intubation.
  • Outcomes such as POI, length of stay (LOS), hospitalization cost, and readmissions were compared between pre- and post-intervention groups.

Main Results:

  • The intervention group showed a significant reduction in POI rates (13.8% vs. 32.6%, p = 0.004).
  • Patients receiving the intervention had significantly lower odds of developing POI (OR 0.33, p = 0.01), with adjusted OR 0.32 (p = 0.01).
  • The intervention was associated with a shorter average post-procedure LOS (5.3 vs. 7.2 days, p < 0.001) and reduced direct costs ($5561 lower, p = 0.004).

Conclusions:

  • The pilot intervention demonstrates potential in reducing post-operative ileus (POI) for patients undergoing ileostomy creation.
  • The findings suggest that modifications to the ERAS protocol may improve surgical outcomes and reduce healthcare resource utilization.
  • Further investigation is warranted to validate these preliminary results and confirm the intervention's effectiveness.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
200
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
402
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
159
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
284
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
283
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
176